Medicine News Car T Cell Therapy Reaches Beyond Cancer Penn Medicine

Next-generation "armored" CAR T cell therapy shows promising results in lymphoma patients

A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas continued to resist multiple rounds of other cancer treatments, including ... Read More

Enhanced CAR T cell therapy offers new strategy for lymphoma

A phase I study of a next-generation CAR T cell therapy showed a 52 percent complete remission rate for patients with relapsed/refractory lymphoma. A next-generation "armored" CAR T cell therapy ... Read More

CAR T cell therapy could be a highly effective tool against atherosclerosis

A pioneering preclinical study has shown that CAR T cell therapy-a personalized form of immunotherapy used in cancer treatment-could be a highly effective tool against atherosclerosis, the condition ... Read More

Penn professor Carl June discusses medical innovation award, CAR-T cell research in DP interview

Penn Medicine professor Carl June was recently awarded the Broermann Medical Innovation Award 2025 for his work on utilizing CAR-T cells in cancer therapy. Modifying T-cells with chimeric antigen ... Read More

CAR-T cell therapy for cancer causes 'brain fog,' study shows

Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, a Stanford Medicine team found. They also identified compounds that could treat it. After treatment with CAR-T cells ... Read More

Dual-Target CAR-T Cell Therapy Slows Glioblastoma Tumors in Phase I Trial

Glioblastoma (GBM) is an aggressive and common brain cancer in adults with average life expectancies of 12–18 months after diagnosis and median survival rate for recurrent GBM ranging from 6–10 months ... Read More

CAR T-Cell Therapy Boosts PFS in Advanced Gastric Cancer

In patients with advanced Claudin-18 isoform 2 (CLDN18.2) -positive gastric or gastroesophageal junction cancers, satricabtagene autoleucel (satri-cel) chimeric antigen receptor (CAR) T-cell therapy ... Read More

CAR-T cell therapy is revolutionizing cancer treatment. Here's how it works

Personalized medicine is already a reality in clinical practice, and CAR-T cell therapy is one of its most promising tools. This innovative approach, which involves genetically modifying the cells of ... Read More

Cutting-Edge Cancer Treatment Isn't Known By Most Americans

CAR T-cell therapy teaches a person’s immune system how to find and attack their specific cancer But 65% of people haven’t heard of the treatment, which for now is approved only in blood cancers ... Read More

CAR T-Cell Therapy: Cancer Treatment to Help Lupus?

ORLANDO, Fla. (Ivanhoe Newswire) — Lupus is a debilitating autoimmune disease that affects around 1.5 million Americans. Now, new research shows a therapy that’s been used for cancer patients may help ... Read More

CAR-T Cell Therapy-Related “Brain Fog” Mechanism and Treatment Approaches Identified

After treatment with CAR-T cells—immune cells engineered to attack cancer—patients sometimes tell their doctors they feel like they have “brain fog,” or forgetfulness and difficulty concentrating. A ... Read More